Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$643M |
| 2 |
AT&T
T
|
+$311M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$306M |
| 4 |
Microsoft
MSFT
|
+$292M |
| 5 |
Ametek
AME
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$887M |
| 2 |
Apple
AAPL
|
+$694M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$616M |
| 4 |
Amazon
AMZN
|
+$596M |
| 5 |
Linde
LIN
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 58.05% |
| 2 | Technology | 7.69% |
| 3 | Financials | 6.83% |
| 4 | Healthcare | 6.42% |
| 5 | Industrials | 4.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2001
Medifast
MED
$136M
| $10.1M | 0.01% |
52,400
+44,100
| +531% | +$10.8M |
|
2002
Medpace
MEDP
$17.1B
| $10.1M | 0.01% |
53,311
+41,979
| +370% | +$7.66M |
|
|
RPAI
2003
DELISTED
RETAIL PROPERTIES OF AMERICA, INC.
RPAI
| $10.1M | 0.01% |
782,704
+222,090
| +40% | +$2.77M |
|
|
FINM
2004
DELISTED
Marlin Technology Corporation Class A Ordinary Share
FINM
| $10.1M | 0.01% |
1,032,814
+463,191
| +81% | +$4.49M |
|
2005
Skywest
SKYW
$3.84B
| $10.1M | 0.01% |
204,256
+84,201
| +70% | +$3.67M |
|
|
TIXT
2006
DELISTED
TELUS International
TIXT
| $10.1M | 0.01% |
287,652
+58,526
| +26% | +$1.89M |
|
|
JUGGU
2007
DELISTED
Jaws Juggernaut Acquisition Corporation Unit
JUGGU
| $10.1M | 0.01% |
999,791
+206
| +0% | +$2.07K |
|
2008
Brilliant Earth
BRLT
$22.1M
| $10.1M | 0.01% |
+751,374
| New | +$10.9M |
|
2009
Cogent Communications
CCOI
$495M
| $10.1M | 0.01% |
141,910
+64,387
| +83% | +$4.79M |
|
|
SOLY
2010
DELISTED
Soliton, Inc.
SOLY
| $10.1M | 0.01% |
493,596
+343,370
| +229% | +$7.34M |
|
2011
Itron
ITRI
$4.35B
| $10M | 0.01% |
132,806
+116,316
| +705% | +$9.97M |
|
|
SCAQU
2012
DELISTED
Stratim Cloud Acquisition Corp. Unit
SCAQU
| $10M | 0.01% |
1,010,476
+2,552
| +0.3% | +$25.3K |
|
|
CCVI
2013
DELISTED
Churchill Capital Corp VI
CCVI
| $10M | 0.01% |
1,027,300
-948,089
| -48% | -$9.33M |
|
|
CSTA
2014
DELISTED
Constellation Acquisition Corp I
CSTA
| $10M | 0.01% |
1,028,190
-60,058
| -6% | -$583K |
|
|
CAS
2015
DELISTED
Cascade Acquisition Corp.
CAS
| $10M | 0.01% |
1,007,724
| – | – |
|
2016
Jack in the Box
JACK
$305M
| $10M | 0.01% |
102,917
+50,476
| +96% | +$5.26M |
|
|
VEI
2017
DELISTED
Vine Energy Inc.
VEI
| $10M | 0.01% |
607,788
-148,691
| -20% | -$2.23M |
|
2018
CALL
Stanley Black & Decker
SWK
$15B
| $9.99M | 0.01% |
+57,000
| New | +$11.1M |
|
2019
NewMarket
NEU
$8.49B
| $9.97M | 0.01% |
29,428
-47,927
| -62% | -$15.7M |
|
2020
Knowles
KN
$2.99B
| $9.96M | 0.01% |
531,623
+287,887
| +118% | +$5.63M |
|
2021
Southwest Gas
SWX
$6.48B
| $9.96M | 0.01% |
148,951
-382,617
| -72% | -$26.7M |
|
2022
Pacific Biosciences
PACB
$482M
| $9.95M | 0.01% |
389,280
-277,725
| -42% | -$8.23M |
|
2023
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.7B
| $9.94M | 0.01% |
20,671
-39,899
| -66% | -$19.6M |
|
2024
Chord Energy
CHRD
$7.99B
| $9.93M | 0.01% |
+99,842
| New | +$9.19M |
|
2025
PUT
Petrobras
PBR
$118B
| $9.93M | 0.01% |
959,900
| – | – |
|
Similar funds
Israel Englander's Q3 2021 Portfolio in Review
As of Q3 2021, Israel Englander held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Israel Englander's Q3 2021 filing shows 1,245 new, 2,719 increased, 2,446 reduced and 981 closed positions. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M. The largest sale was Alexion Pharmaceuticals, an estimated $887M.
By sector, the portfolio is most concentrated in Miscellaneous at 58% of assets, up from 55% a quarter earlier, followed by Technology and Financials.
- Israel Englander's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
- Israel Englander's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
- Israel Englander fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
- Israel Englander's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
- Israel Englander opened 1,245 new positions and closed 981 in Q3 2021.
- Israel Englander's portfolio value rose 2.3% quarter-over-quarter to $167B.
Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.